🇺🇸 No oral drug therapy throughout the pollen period in United States

No oral drug therapy throughout the pollen period (No oral drug therapy throughout the pollen period) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

No oral drug therapy throughout the pollen period in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is No oral drug therapy throughout the pollen period approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for No oral drug therapy throughout the pollen period in United States?

Beijing Tongren Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.